Clinic
Community Health Project INC.
Community Health Project INC. was paid $27.39M by Medicaid between Jan 2018 and Dec 2024, across 71 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 45% of everything it billed.
33Billing provider infoCOMMUNITY HEALTH PROJECT INC.
NEW YORK, NY 10011
NEW YORK, NY 10011
33aNPI1306898432assigned 05/17/2006
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$27.39M
24GClaims314,251
24DCodes billed71
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in New York
Rank by total paid#17 of 158
Median peer was paid$1.73M
This provider vs. median16×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 48,182 | $4.07M | |
| 2019 | 54,991 | $4.29M | |
| 2020 | 44,997 | $4.22M | |
| 2021 | 43,723 | $4.30M | |
| 2022 | 22,274 | $2.36M | |
| 2023 | 43,138 | $3.34M | |
| 2024incomplete | 56,946 | $4.81M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 45% | 124,860 | 75,075 | $12.27M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 21% | 54,873 | 34,778 | $5.85M |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | 15% | 28,567 | 9,284 | $4.16M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 8.0% | 32,589 | 14,812 | $2.20M |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | 1.2% | 2,043 | 1,412 | $317K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 15,123 | 11,610 | $266K |
| J0741 | Injection, cabotegravir and rilpivirine, 2mg/3mg | <1% | 55 | 55 | $208K |
| D0274 | Bitewings - four radiographic images | <1% | 5,044 | 1,803 | $207K |
| 90834 | Psychotherapy session, about 45 minutesPsychotherapy, 45 minutes with patient | <1% | 1,350 | 565 | $185K |
| D0120 | Dental checkup, returning patientPeriodic oral evaluation - established patient | <1% | 4,250 | 2,316 | $182K |
| 90792 | Psychiatric diagnostic evaluation with medical services | <1% | 1,234 | 1,202 | $158K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 2,621 | 1,286 | $143K |
59 more codes
| D1110 | Prophylaxis - adult | <1% | 3,114 | $140K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 7,844 | $124K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 1,087 | $122K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,218 | $122K |
| D0140 | Limited oral evaluation - problem focused | <1% | 1,016 | $97K |
| J0739 | Injection, cabotegravir, 1mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv) | <1% | 30 | $88K |
| J1380 | Injection, estradiol valerate, up to 10 mg | <1% | 4,823 | $59K |
| 90686 | <1% | 3,312 | $57K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 8,477 | $42K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 304 | $39K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | <1% | 798 | $32K |
| 46607 | <1% | 162 | $31K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 265 | $22K |
| 90734 | <1% | 290 | $21K | |
| 90677 | <1% | 100 | $18K | |
| G0467 | Community health center visit, returning patient | <1% | 375 | $17K |
| D2391 | Resin-based composite - one surface, posterior, primary or permanent | <1% | 156 | $15K |
| 90739 | <1% | 179 | $13K | |
| 0064A | <1% | 329 | $13K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 947 | $12K |
| D0270 | <1% | 250 | $12K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 124 | $11K |
| 0012A | <1% | 272 | $11K | |
| 98966 | <1% | 82 | $10K | |
| 0011A | <1% | 311 | $10K | |
| 99442 | <1% | 110 | $10K | |
| 90651 | <1% | 171 | $9K | |
| 98967 | <1% | 88 | $9K | |
| 90750 | <1% | 76 | $7K | |
| 90715 | <1% | 265 | $7K | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 144 | $7K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 425 | $6K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 147 | $6K |
| 90732 | <1% | 53 | $5K | |
| 99441 | <1% | 69 | $4K | |
| D2393 | Resin-based composite - three surfaces, posterior, primary or permanent | <1% | 43 | $4K |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 162 | $4K |
| 11100 | <1% | 55 | $4K | |
| 90674 | <1% | 254 | $3K | |
| D9991 | <1% | 61 | $3K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 40 | $3K |
| 0134A | <1% | 68 | $3K | |
| 90656 | <1% | 195 | $2K | |
| D0330 | Panoramic radiographic image | <1% | 41 | $2K |
| 90670 | <1% | 13 | $2K | |
| D9110 | <1% | 18 | $2K | |
| 99443 | <1% | 16 | $2K | |
| 0031A | <1% | 32 | $1K | |
| 90707 | <1% | 29 | $957.00 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,591 | $911.65 |
| 90733 | <1% | 12 | $892.38 | |
| 99051 | <1% | 56 | $489.85 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 55 | $366.30 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 13 | $182.66 |
| J1071 | Injection, testosterone cypionate, 1 mg | <1% | 1,279 | $2.79 |
| 91313 | <1% | 30 | $0.01 | |
| 99429 | 0% | 15 | $0.00 | |
| 90611 | 0% | 121 | $0.00 | |
| 99499 | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMARTIN, NICHOLAS (COMPLIANCE ANALYST)
| Provider | Location | Paid |
|---|---|---|
| Community Health Project INC. | Bronx, NY | $4.91M |
| Summit Physical Therapy INC | Follansbee, WV | $15K |
| Summit Physical Therapy INC | New Cumberland, WV | $4K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.